Literature DB >> 6122540

Fibrosing alveolitis, bronchiolitis obliterans, and sulfasalazine therapy.

T Williams, L Eidus, P Thomas.   

Abstract

A patient with ulcerative colitis had extensive upper zone pulmonary disease while taking sulfasalazine. Pulmonary function tests showed progressive restrictive and obstructive disease. Lung biopsy showed bronchiolitis obliterans and chronic interstitial pneumonia or fibrosing alveolitis with a mild eosinophilic infiltrate. The patient improved after receiving steroid therapy. A review of the literature of lung disease related to ulcerative colitis and sulfasalazine is presented.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6122540     DOI: 10.1378/chest.81.6.766

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

Review 1.  Organising pneumonia.

Authors:  J F Cordier
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

2.  BOOP and COP.

Authors:  D M Geddes
Journal:  Thorax       Date:  1991-08       Impact factor: 9.139

3.  Organizing pneumonia: a rare pulmonary manifestation of well-controlled ulcerative colitis.

Authors:  Xiaoming Zhou; Yu Chen; Li Zhao
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

4.  Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies.

Authors:  P Bonniere; B Wallaert; A Cortot; X Marchandise; Y Riou; A B Tonnel; J F Colombel; C Voisin; J C Paris
Journal:  Gut       Date:  1986-08       Impact factor: 23.059

Review 5.  Extraintestinal manifestations and complications in inflammatory bowel diseases.

Authors:  Katja S Rothfuss; Eduard F Stange; Klaus R Herrlinger
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

Review 6.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

7.  Bronchiolitis obliterans organising pneumonia in patients taking acebutolol or amiodarone.

Authors:  P Camus; J N Lombard; M Perrichon; F Piard; J C Guérin; F B Thivolet; L Jeannin
Journal:  Thorax       Date:  1989-09       Impact factor: 9.139

Review 8.  Drug-induced respiratory disorders: incidence, prevention and management.

Authors:  L Ben-Noun
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.606

9.  Sulfasalazine-induced pulmonary disease.

Authors:  R H Moseley; K W Barwick; K Dobuler; V A DeLuca
Journal:  Dig Dis Sci       Date:  1985-09       Impact factor: 3.199

Review 10.  Pulmonary involvement and allergic disorders in inflammatory bowel disease.

Authors:  Nikolaos E Tzanakis; Ioanna G Tsiligianni; Nikolaos M Siafakas
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.